Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ami B Patel

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Leukemia|May 16, 2020
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanismsAmi B Patel, Anthony D Pomicter, Dongqing Yan, et al.
The Journal of Infectious Diseases|April 24, 2024
Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and CancerNancy Gillis, Brittney L Dickey, Christelle Colin-Leitzinger, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2021
Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort StudyPriya R Edward, Ramon Lorenzo-Redondo, Megan E Reyna, et al.
Journal of the Pediatric Infectious Diseases Society|August 4, 2022
Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort StudyPriya R Edward, Ramon Lorenzo-Redondo, Megan E Reyna, et al.
Chemmedchem|March 31, 2016
Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic LiabilitiesAhmed M Ali, Rodolfo F Gómez-Biagi, David A Rosa, et al.
Blood|April 23, 2017
miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon responseJared A Wallace, Dominique A Kagele, Anna M Eiring, et al.
Blood|November 8, 2019
JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia veraAmi B Patel, Anca Franzini, Emilie Leroy, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2026
Identification of <i>Streptococcus pyogenes</i> isolates with reduced beta-lactam susceptibility in a cohort of children with pharyngitisDaniel B Amusin, Lacy M Simons, Dulce S Garcia, et al.
Journal of Clinical Pathology|June 26, 2025
Karyotypic clonal fraction predicts adverse outcome in <i>TP53</i>-mutated myeloid neoplasms: an International <i>TP53</i> investigators Network (iTiN) studyMadhavi Pandiri, Anna Stengel, Jingjing Zhang, et al.
Blood|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasmsNicole S Arellano, William L Heaton, Mirielle C Nauman, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Leukemia|May 16, 2020
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanismsAmi B Patel, Anthony D Pomicter, Dongqing Yan, et al.
The Journal of Infectious Diseases|April 24, 2024
Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and CancerNancy Gillis, Brittney L Dickey, Christelle Colin-Leitzinger, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2021
Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort StudyPriya R Edward, Ramon Lorenzo-Redondo, Megan E Reyna, et al.
Journal of the Pediatric Infectious Diseases Society|August 4, 2022
Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort StudyPriya R Edward, Ramon Lorenzo-Redondo, Megan E Reyna, et al.
Chemmedchem|March 31, 2016
Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic LiabilitiesAhmed M Ali, Rodolfo F Gómez-Biagi, David A Rosa, et al.
Blood|April 23, 2017
miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon responseJared A Wallace, Dominique A Kagele, Anna M Eiring, et al.
Blood|November 8, 2019
JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia veraAmi B Patel, Anca Franzini, Emilie Leroy, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2026
Identification of <i>Streptococcus pyogenes</i> isolates with reduced beta-lactam susceptibility in a cohort of children with pharyngitisDaniel B Amusin, Lacy M Simons, Dulce S Garcia, et al.
Journal of Clinical Pathology|June 26, 2025
Karyotypic clonal fraction predicts adverse outcome in <i>TP53</i>-mutated myeloid neoplasms: an International <i>TP53</i> investigators Network (iTiN) studyMadhavi Pandiri, Anna Stengel, Jingjing Zhang, et al.
Blood|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasmsNicole S Arellano, William L Heaton, Mirielle C Nauman, et al.
Pageof 5